APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Zoster Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Recombinant Zoster Vaccine Market Analysis and Forecast 2026-2032

30 December 2025194 pages

Choose your research edition.

Industry ResearchRecombinant Zoster Vaccine Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Zoster Vaccine Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Recombinant Zoster Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Zoster Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Zoster Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Recombinant Zoster Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant Zoster Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Recombinant Zoster Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Recombinant Zoster Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Recombinant Zoster Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Recombinant Zoster Vaccine include GSK, Merck and Changchun Bcht Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Recombinant Zoster Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Recombinant Zoster Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Recombinant Zoster Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Zoster Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Recombinant Zoster Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Recombinant Zoster Vaccine sales, projected growth trends, production technology, application and end-user industry.

Recombinant Zoster Vaccine Segment by Company

GSK

Merck

Changchun Bcht Biotechnology

Recombinant Zoster Vaccine Segment by Type

Monovalent Vaccine

Combination Vaccine

Recombinant Zoster Vaccine Segment by Application

Above 50 Years Old

Below 50 Years Old

Recombinant Zoster Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Zoster Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Zoster Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Zoster Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Recombinant Zoster Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Recombinant Zoster Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Zoster Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Recombinant Zoster Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Monovalent Vaccine Major Manufacturers Table 3. Combination Vaccine Major Manufacturers Table 4. Global Recombinant Zoster Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Above 50 Years Old Major Manufacturers Table 6. Below 50 Years Old Major Manufacturers Table 7. Recombinant Zoster Vaccine Industry Trends Table 8. Recombinant Zoster Vaccine Industry Drivers Table 9. Recombinant Zoster Vaccine Industry Opportunities and Challenges Table 10. Recombinant Zoster Vaccine Industry Restraints Table 11. Global Recombinant Zoster Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Recombinant Zoster Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Recombinant Zoster Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Recombinant Zoster Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Recombinant Zoster Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Recombinant Zoster Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Recombinant Zoster Vaccine Sales by Region (2021-2026) & (K Units) Table 18. Global Recombinant Zoster Vaccine Sales by Region (2027-2032) & (K Units) Table 19. Global Recombinant Zoster Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Recombinant Zoster Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Recombinant Zoster Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Recombinant Zoster Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Recombinant Zoster Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Recombinant Zoster Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Recombinant Zoster Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Recombinant Zoster Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Recombinant Zoster Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Recombinant Zoster Vaccine Manufacturers, Product Type & Application Table 29. Global Recombinant Zoster Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Recombinant Zoster Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Recombinant Zoster Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Recombinant Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Recombinant Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Recombinant Zoster Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Recombinant Zoster Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Recombinant Zoster Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Recombinant Zoster Vaccine Sales by Type (2021-2026) & (K Units) Table 39. Global Recombinant Zoster Vaccine Sales by Type (2027-2032) & (K Units) Table 40. Global Recombinant Zoster Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Recombinant Zoster Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Recombinant Zoster Vaccine Price by Type (2021-2026) & (US$/Unit) Table 43. Global Recombinant Zoster Vaccine Price by Type (2027-2032) & (US$/Unit) Table 44. Global Recombinant Zoster Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Recombinant Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Recombinant Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Recombinant Zoster Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Recombinant Zoster Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Recombinant Zoster Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Recombinant Zoster Vaccine Sales by Application (2021-2026) & (K Units) Table 51. Global Recombinant Zoster Vaccine Sales by Application (2027-2032) & (K Units) Table 52. Global Recombinant Zoster Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Recombinant Zoster Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Recombinant Zoster Vaccine Price by Application (2021-2026) & (US$/Unit) Table 55. Global Recombinant Zoster Vaccine Price by Application (2027-2032) & (US$/Unit) Table 56. GSK Company Information Table 57. GSK Business Overview Table 58. GSK Recombinant Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. GSK Recombinant Zoster Vaccine Product Portfolio Table 60. GSK Recent Development Table 61. Merck Company Information Table 62. Merck Business Overview Table 63. Merck Recombinant Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Merck Recombinant Zoster Vaccine Product Portfolio Table 65. Merck Recent Development Table 66. Changchun Bcht Biotechnology Company Information Table 67. Changchun Bcht Biotechnology Business Overview Table 68. Changchun Bcht Biotechnology Recombinant Zoster Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Changchun Bcht Biotechnology Recombinant Zoster Vaccine Product Portfolio Table 70. Changchun Bcht Biotechnology Recent Development Table 71. North America Recombinant Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 72. North America Recombinant Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 73. North America Recombinant Zoster Vaccine Sales by Type (2021-2026) & (K Units) Table 74. North America Recombinant Zoster Vaccine Sales by Type (2027-2032) & (K Units) Table 75. North America Recombinant Zoster Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 76. North America Recombinant Zoster Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 77. North America Recombinant Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Recombinant Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Recombinant Zoster Vaccine Sales by Application (2021-2026) & (K Units) Table 80. North America Recombinant Zoster Vaccine Sales by Application (2027-2032) & (K Units) Table 81. North America Recombinant Zoster Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 82. North America Recombinant Zoster Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 83. North America Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. North America Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 85. North America Recombinant Zoster Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 86. North America Recombinant Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 87. North America Recombinant Zoster Vaccine Sales by Country (2021-2026) & (K Units) Table 88. North America Recombinant Zoster Vaccine Sales by Country (2027-2032) & (K Units) Table 89. North America Recombinant Zoster Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 90. North America Recombinant Zoster Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 91. United States Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 92. Canada Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 93. Europe Recombinant Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Recombinant Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Recombinant Zoster Vaccine Sales by Type (2021-2026) & (K Units) Table 96. Europe Recombinant Zoster Vaccine Sales by Type (2027-2032) & (K Units) Table 97. Europe Recombinant Zoster Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 98. Europe Recombinant Zoster Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 99. Europe Recombinant Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 100. Europe Recombinant Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 101. Europe Recombinant Zoster Vaccine Sales by Application (2021-2026) & (K Units) Table 102. Europe Recombinant Zoster Vaccine Sales by Application (2027-2032) & (K Units) Table 103. Europe Recombinant Zoster Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 104. Europe Recombinant Zoster Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 105. Europe Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Europe Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. Europe Recombinant Zoster Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. Europe Recombinant Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 109. Europe Recombinant Zoster Vaccine Sales by Country (2021-2026) & (K Units) Table 110. Europe Recombinant Zoster Vaccine Sales by Country (2027-2032) & (K Units) Table 111. Europe Recombinant Zoster Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 112. Europe Recombinant Zoster Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 113. Germany Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 114. France Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 115. U.K. Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 116. Italy Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 118. China Recombinant Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 119. China Recombinant Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 120. China Recombinant Zoster Vaccine Sales by Type (2021-2026) & (K Units) Table 121. China Recombinant Zoster Vaccine Sales by Type (2027-2032) & (K Units) Table 122. China Recombinant Zoster Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 123. China Recombinant Zoster Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 124. China Recombinant Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 125. China Recombinant Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 126. China Recombinant Zoster Vaccine Sales by Application (2021-2026) & (K Units) Table 127. China Recombinant Zoster Vaccine Sales by Application (2027-2032) & (K Units) Table 128. China Recombinant Zoster Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 129. China Recombinant Zoster Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 130. Asia Recombinant Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia Recombinant Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia Recombinant Zoster Vaccine Sales by Type (2021-2026) & (K Units) Table 133. Asia Recombinant Zoster Vaccine Sales by Type (2027-2032) & (K Units) Table 134. Asia Recombinant Zoster Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 135. Asia Recombinant Zoster Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 136. Asia Recombinant Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 137. Asia Recombinant Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Recombinant Zoster Vaccine Sales by Application (2021-2026) & (K Units) Table 139. Asia Recombinant Zoster Vaccine Sales by Application (2027-2032) & (K Units) Table 140. Asia Recombinant Zoster Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 141. Asia Recombinant Zoster Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Asia Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Asia Recombinant Zoster Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Asia Recombinant Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 146. Asia Recombinant Zoster Vaccine Sales by Country (2021-2026) & (K Units) Table 147. Asia Recombinant Zoster Vaccine Sales by Country (2027-2032) & (K Units) Table 148. Asia Recombinant Zoster Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 149. Asia Recombinant Zoster Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 150. Japan Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 151. South Korea Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 152. India Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 153. Australia Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 154. China Taiwan Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 155. Southeast Asia Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 156. SAMEA Recombinant Zoster Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 157. SAMEA Recombinant Zoster Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 158. SAMEA Recombinant Zoster Vaccine Sales by Type (2021-2026) & (K Units) Table 159. SAMEA Recombinant Zoster Vaccine Sales by Type (2027-2032) & (K Units) Table 160. SAMEA Recombinant Zoster Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 161. SAMEA Recombinant Zoster Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 162. SAMEA Recombinant Zoster Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 163. SAMEA Recombinant Zoster Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 164. SAMEA Recombinant Zoster Vaccine Sales by Application (2021-2026) & (K Units) Table 165. SAMEA Recombinant Zoster Vaccine Sales by Application (2027-2032) & (K Units) Table 166. SAMEA Recombinant Zoster Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 167. SAMEA Recombinant Zoster Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 168. SAMEA Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. SAMEA Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. SAMEA Recombinant Zoster Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. SAMEA Recombinant Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 172. SAMEA Recombinant Zoster Vaccine Sales by Country (2021-2026) & (K Units) Table 173. SAMEA Recombinant Zoster Vaccine Sales by Country (2027-2032) & (K Units) Table 174. SAMEA Recombinant Zoster Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 175. SAMEA Recombinant Zoster Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 176. Brazil Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 177. Argentina Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 178. Chile Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 179. Colombia Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 180. Peru Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Saudi Arabia Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 182. Israel Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 183. UAE Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Turkey Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Iran Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Egypt Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Recombinant Zoster Vaccine Distributors List Table 190. Recombinant Zoster Vaccine Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Recombinant Zoster Vaccine Image Figure 2. Global Recombinant Zoster Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Zoster Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Monovalent Vaccine Image Figure 5. Combination Vaccine Image Figure 6. Global Recombinant Zoster Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Recombinant Zoster Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Above 50 Years Old Image Figure 9. Below 50 Years Old Image Figure 10. Global Recombinant Zoster Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Recombinant Zoster Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Recombinant Zoster Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Recombinant Zoster Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Recombinant Zoster Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Recombinant Zoster Vaccine Sales (2021-2032) & (K Units) Figure 16. Global Recombinant Zoster Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Recombinant Zoster Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Recombinant Zoster Vaccine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Recombinant Zoster Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. China Recombinant Zoster Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Recombinant Zoster Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Recombinant Zoster Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Global Recombinant Zoster Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Recombinant Zoster Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Recombinant Zoster Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Recombinant Zoster Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Recombinant Zoster Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Recombinant Zoster Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Recombinant Zoster Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Recombinant Zoster Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Recombinant Zoster Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Recombinant Zoster Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Recombinant Zoster Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Recombinant Zoster Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Recombinant Zoster Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Recombinant Zoster Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Recombinant Zoster Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Recombinant Zoster Vaccine Sales Share by Type (2021-2032) Figure 40. North America Recombinant Zoster Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Recombinant Zoster Vaccine Sales Share by Application (2021-2032) Figure 42. North America Recombinant Zoster Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Recombinant Zoster Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Recombinant Zoster Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Recombinant Zoster Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Recombinant Zoster Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Recombinant Zoster Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Recombinant Zoster Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Recombinant Zoster Vaccine Sales Share by Country (2021-2032) Figure 50. China Recombinant Zoster Vaccine Revenue Share by Type (2021-2032) Figure 51. China Recombinant Zoster Vaccine Sales Share by Type (2021-2032) Figure 52. China Recombinant Zoster Vaccine Revenue Share by Application (2021-2032) Figure 53. China Recombinant Zoster Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Recombinant Zoster Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Recombinant Zoster Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Recombinant Zoster Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Recombinant Zoster Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Recombinant Zoster Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Recombinant Zoster Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Recombinant Zoster Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Recombinant Zoster Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Recombinant Zoster Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Recombinant Zoster Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Recombinant Zoster Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Recombinant Zoster Vaccine Sales Share by Country (2021-2032) Figure 66. Recombinant Zoster Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Recombinant Zoster Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccine
  • Combination Vaccine
Applications
  • Above 50 Years Old
  • Below 50 Years Old
Companies covered
  • GSK
  • Merck
  • Changchun Bcht Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Recombinant Zoster Vaccine Market by Type
  3. 1.2.1 Global Recombinant Zoster Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Monovalent Vaccine
  5. 1.2.3 Combination Vaccine
  6. 1.3 Recombinant Zoster Vaccine Market by Application
  7. 1.3.1 Global Recombinant Zoster Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Above 50 Years Old
  9. 1.3.3 Below 50 Years Old
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Recombinant Zoster Vaccine Market Dynamics
  1. 2.1 Recombinant Zoster Vaccine Industry Trends
  2. 2.2 Recombinant Zoster Vaccine Industry Drivers
  3. 2.3 Recombinant Zoster Vaccine Industry Opportunities and Challenges
  4. 2.4 Recombinant Zoster Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Recombinant Zoster Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Recombinant Zoster Vaccine Revenue by Region
  3. 3.2.1 Global Recombinant Zoster Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Recombinant Zoster Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Recombinant Zoster Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Recombinant Zoster Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Recombinant Zoster Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Recombinant Zoster Vaccine Sales by Region
  9. 3.4.1 Global Recombinant Zoster Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Recombinant Zoster Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Recombinant Zoster Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Recombinant Zoster Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Recombinant Zoster Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Recombinant Zoster Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Recombinant Zoster Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Recombinant Zoster Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Recombinant Zoster Vaccine Sales by Manufacturers
  6. 4.2.1 Global Recombinant Zoster Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Recombinant Zoster Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Recombinant Zoster Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Recombinant Zoster Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Recombinant Zoster Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Recombinant Zoster Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Recombinant Zoster Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Recombinant Zoster Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Recombinant Zoster Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Recombinant Zoster Vaccine Tier 1, Tier 2, and Tier 3
5 Recombinant Zoster Vaccine Market by Type
  1. 5.1 Global Recombinant Zoster Vaccine Revenue by Type
  2. 5.1.1 Global Recombinant Zoster Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Recombinant Zoster Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Recombinant Zoster Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Recombinant Zoster Vaccine Sales by Type
  6. 5.2.1 Global Recombinant Zoster Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Zoster Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Recombinant Zoster Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Recombinant Zoster Vaccine Price by Type
6 Recombinant Zoster Vaccine Market by Application
  1. 6.1 Global Recombinant Zoster Vaccine Revenue by Application
  2. 6.1.1 Global Recombinant Zoster Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Recombinant Zoster Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Recombinant Zoster Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Recombinant Zoster Vaccine Sales by Application
  6. 6.2.1 Global Recombinant Zoster Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Recombinant Zoster Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Recombinant Zoster Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Recombinant Zoster Vaccine Price by Application
7 Company Profiles
  1. 7.1 GSK
  2. 7.1.1 GSK Company Information
  3. 7.1.2 GSK Business Overview
  4. 7.1.3 GSK Recombinant Zoster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 GSK Recombinant Zoster Vaccine Product Portfolio
  6. 7.1.5 GSK Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Recombinant Zoster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Recombinant Zoster Vaccine Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Changchun Bcht Biotechnology
  14. 7.3.1 Changchun Bcht Biotechnology Company Information
  15. 7.3.2 Changchun Bcht Biotechnology Business Overview
  16. 7.3.3 Changchun Bcht Biotechnology Recombinant Zoster Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Changchun Bcht Biotechnology Recombinant Zoster Vaccine Product Portfolio
  18. 7.3.5 Changchun Bcht Biotechnology Recent Developments
8 North America
  1. 8.1 North America Recombinant Zoster Vaccine Market Size by Type
  2. 8.1.1 North America Recombinant Zoster Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Recombinant Zoster Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Recombinant Zoster Vaccine Price by Type (2021-2032)
  5. 8.2 North America Recombinant Zoster Vaccine Market Size by Application
  6. 8.2.1 North America Recombinant Zoster Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Recombinant Zoster Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Recombinant Zoster Vaccine Price by Application (2021-2032)
  9. 8.3 North America Recombinant Zoster Vaccine Market Size by Country
  10. 8.3.1 North America Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Recombinant Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Recombinant Zoster Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Recombinant Zoster Vaccine Market Size by Type
  2. 9.1.1 Europe Recombinant Zoster Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Recombinant Zoster Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Recombinant Zoster Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Recombinant Zoster Vaccine Market Size by Application
  6. 9.2.1 Europe Recombinant Zoster Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Recombinant Zoster Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Recombinant Zoster Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Recombinant Zoster Vaccine Market Size by Country
  10. 9.3.1 Europe Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Recombinant Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Recombinant Zoster Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Recombinant Zoster Vaccine Market Size by Type
  2. 10.1.1 China Recombinant Zoster Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Recombinant Zoster Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Recombinant Zoster Vaccine Price by Type (2021-2032)
  5. 10.2 China Recombinant Zoster Vaccine Market Size by Application
  6. 10.2.1 China Recombinant Zoster Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Recombinant Zoster Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Recombinant Zoster Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Recombinant Zoster Vaccine Market Size by Type
  2. 11.1.1 Asia Recombinant Zoster Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Recombinant Zoster Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Recombinant Zoster Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Recombinant Zoster Vaccine Market Size by Application
  6. 11.2.1 Asia Recombinant Zoster Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Recombinant Zoster Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Recombinant Zoster Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Recombinant Zoster Vaccine Market Size by Country
  10. 11.3.1 Asia Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Recombinant Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Recombinant Zoster Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Recombinant Zoster Vaccine Market Size by Type
  2. 12.1.1 SAMEA Recombinant Zoster Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Recombinant Zoster Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Recombinant Zoster Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Recombinant Zoster Vaccine Market Size by Application
  6. 12.2.1 SAMEA Recombinant Zoster Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Recombinant Zoster Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Recombinant Zoster Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Recombinant Zoster Vaccine Market Size by Country
  10. 12.3.1 SAMEA Recombinant Zoster Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Recombinant Zoster Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Recombinant Zoster Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Recombinant Zoster Vaccine Value Chain Analysis
  2. 13.1.1 Recombinant Zoster Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Recombinant Zoster Vaccine Production Mode & Process
  6. 13.2 Recombinant Zoster Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Recombinant Zoster Vaccine Distributors
  9. 13.2.3 Recombinant Zoster Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst